REGENXBIO Inc. (RGNX)

Healthcare Inconclusive inconclusive weak

$7.15

Updated: 2026-10-20

TradeApes Score

Financial Strength

26 Stressed

Operating Trend

56 Mixed

Relative Value

35 Overvalued

Capital Allocation

21 Stressed

Risk Management

34 Weak

Key Findings

+ operating-margin trend + inflection

Unlock Full Report →

− free-cash-flow yield

Unlock Full Report →

Industry Related Stocks

Acumen Pharmaceuticals, Inc. (ABOS) Abpro Holdings, Inc. (ABPO) Abpro Holdings, Inc. (ABPWW) Arcellx, Inc. (ACLX) Alpha Cognition Inc. (ACOG) ADMA BIOLOGICS, INC. (ADMA)

See all Healthcare stocks →

Get RGNX and 3,000+ stocks in your pocket

Health scores, fair-value estimates, and full company analysis — free on iPhone.

Download iPhone App

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.